Essential amino acid tryptophan inhibits induction of inducible nitric oxide synthase gene expression in interleukin-1β stimulated hepatocytes
DOI:
https://doi.org/10.31989/bchd.v2i7.639Аннотация
Background: Tryptophan exerts protective effects against a variety of organ inflammation and injury, including the liver. However, there are few scientific reports about the mechanisms involved with the action. Pro-inflammatory cytokine interleukin (IL)-1β stimulates the induction of inducible nitric oxide synthase (iNOS) expression and NO production in cultured hepatocytes (“in vitro liver injury model”). Additionally, the prevention of iNOS expression and NO production is an indicator of liver protection. Thus, the study aimed to examine whether tryptophan influences the induction of iNOS gene expression and the mechanisms.
Methods: Tryptophan was added into primary cultures of rat hepatocytes stimulated by IL-1β. The iNOS induction, NO production, and its signaling pathway were analyzed.
Results: IL-1β induced iNOS gene expression, which was followed by iNOS expression and NO production. Tryptophan inhibited the expression of iNOS mRNA and protein, in addition to decreasing the production of NO. Transfection experiments with iNOS promoter-luciferase constructs revealed that tryptophan reduced the activities of iNOS mRNA synthesis and its stability. Tryptophan blocked two essential signaling pathways, the activation of nuclear factor (NF)-κB and upregulation of type I IL-1receptor (IL-1RI).
Conclusions: Results indicate that tryptophan can prevent the NO production by inhibition of iNOS gene expression, partly through NF-κB activation and IL-1RI upregulation in inflamed hepatocytes. Tryptophan may be a potential therapeutic treatment in injured organs, including the liver.
Keywords: tryptophan, inducible nitric oxide synthase, nitric oxide, cultured hepatocytes, nuclear factor-κB, type I interleukin-1 receptor
Опубликован
Выпуск
Раздел
Лицензия
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.